Von Willebrand Disease (VWD) Treatment Market
According to Intent Market Research, the Von Willebrand Disease (VWD) Treatment Market is expected to grow from USD 978.3 million in 2024-e at a CAGR of 11.8% to touch USD 1,912.9 million by 2030. The Von Willebrand Disease (VWD) Treatment Market is dominated by key players such as, CSL Behring, Baxter International Inc., Grifols, Bayer AG, and Octapharma AG.